[Clinical effectiveness of cordarone in combination with other anti-arrhythmia agents in refractory atrial fibrillation and adverse effects of the drugs].
The study was undertaken to examine 105 patients with various circulatory diseases complicated by atrial fibrillation. Patients with refractory atrial fibrillation who had taken combined antiarrhythmic therapy were found to be more responsive to the combinations of cordarone + kinilentin (quinidine disulphate) and cordarone + ethacizin. The combinations of cordarone+digoxin and cordarone + finoptin were demonstrated to be less beneficial.
Denisiuk
V I
VI
Lipnitskiĭ
T N
TN
Kotsuta
G I
GI
Pilipchuk
V P
VP
Stepaniuk
A V
AV
Osiadlaia
E S
ES
D000328:Adult; D000368:Aged; D000638:Amiodarone / Q000008:administration & dosage* / Q000009:adverse effects; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage; D001281:Atrial Fibrillation / Q000188:drug therapy*; D004077:Digoxin / Q000008:administration & dosage / Q000009:adverse effects; D004359:Drug Therapy, Combination; D006801:Humans; D008875:Middle Aged; D016293:Moricizine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D011802:Quinidine / Q000008:administration & dosage / Q000009:adverse effects; D014700:Verapamil / Q000008:administration & dosage / Q000009:adverse effects
D000889:Anti-Arrhythmia Agents; C027240:diethylamino-ethmozine; D016293:Moricizine; C009764:quinidine bisulfate; D004077:Digoxin; D014700:Verapamil; D011802:Quinidine; D000638:Amiodarone
Klinicheskaia éffektivnost' kordarona v sochetanii s drugimi antiaritmicheskimi preparatami pri refrakternoĭ k terapii forme mertsaniia predserdiĭ i pobochnye deĭstviia primeniaemykh lekarstv.